Filing Details

Accession Number:
0001209191-23-007575
Form Type:
5
Zero Holdings:
No
Publication Time:
2023-02-07 16:53:40
Reporting Period:
2022-12-31
Accepted Time:
2023-02-07 16:53:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1641281 Bolt Biotherapeutics Inc. BOLT () 5
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604763 C Randall Schatzman C/O Bolt Biotherapeutics, Inc.
900 Chesapeake Drive
Redwood City CA 94063
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-06 2,500 $1.64 5,359 No 5 P Direct
Common Stock Acquisiton 2022-12-06 2,500 $1.18 7,859 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
No 5 P Direct
Footnotes
  1. Shares acquired under the issuer's Employee Stock Purchase Plan.